Steven M. Paul, Director at Sage Therapeutics, Inc. (SAGE), sold 20,000 shares at $52.69 ($1.0M) on 2015-09-01, disclosed to the SEC on 2015-09-02.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.10 | 9,518 | $496K | 47.3% |
| 2 | $52.69 | 10,482 | $552K | 52.7% |
| Total | $52.41 avg | 20,000 | $1.0M | 100% |
| Filing → |
| KRTX | BUY | 2021-08-18 | $501K | — | Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |